This content is restricted.
Brief
The Human Medicines Regulations 2012 provides lists of approved countries for importing medicines, batch testing, and manufacturing active substances with UK equivalent standards. These lists enable UK importers and wholesalers to continue recognizing QP certification and regulatory standards for active substance manufacture in certain countries. The acceptance of batch testing done in EEA countries will be reviewed before 31 December 2022, with a two-year notice period given in the case of changes.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested